Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela J Higgins

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|April 1, 2010
The androgen receptor in breast cancer: learning from the pastMichaela J Higgins, Antonio C Wolff
Oncology (Williston Park, N.Y.)|June 20, 2008
Therapeutic options in the management of metastatic breast cancerMichaela J Higgins, Antonio C Wolff
Menopause (New York, N.Y.)|June 14, 2013
Endocrine therapy for breast cancer: a tough pill to swallowKerry L Reynolds, Michaela J Higgins
Expert Review of Anticancer Therapy|October 16, 2009
Chemotherapy for lung cancer: the state of the art in 2009Michaela J Higgins, David S Ettinger
Oncology (Williston Park, N.Y.)|September 26, 2009
New directions in the systemic treatment of metastatic thyroid cancerMichaela J Higgins, Arlene Forastiere, Shanthi Marur
The New England Journal of Medicine|September 21, 2022
Trastuzumab Deruxtecan in HER2-Low Breast CancerHailey K Carroll, Michaela J Higgins, Seamus O'Reilly
Current Breast Cancer Reports|November 29, 2014
The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular CharacterizationSasmit Sarangi, Kailash Mosulpuria, Michaela J Higgins, et al.
Acta Oncologica (Stockholm, Sweden)|December 14, 2011
Denosumab and the current status of bone-modifying drugs in breast cancerBrittany L Lee, Michaela J Higgins, Paul E Goss
Breast Care (Basel, Switzerland)|August 9, 2017
Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast CancerDara B Bracken-Clarke, Mairi W Lucas, Michaela J Higgins
Critical Reviews in Oncology/Hematology|November 3, 2012
Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trialMichaela J Higgins, Pedro E R Liedke, Paul E Goss
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|April 1, 2010
The androgen receptor in breast cancer: learning from the pastMichaela J Higgins, Antonio C Wolff
Oncology (Williston Park, N.Y.)|June 20, 2008
Therapeutic options in the management of metastatic breast cancerMichaela J Higgins, Antonio C Wolff
Menopause (New York, N.Y.)|June 14, 2013
Endocrine therapy for breast cancer: a tough pill to swallowKerry L Reynolds, Michaela J Higgins
Expert Review of Anticancer Therapy|October 16, 2009
Chemotherapy for lung cancer: the state of the art in 2009Michaela J Higgins, David S Ettinger
Oncology (Williston Park, N.Y.)|September 26, 2009
New directions in the systemic treatment of metastatic thyroid cancerMichaela J Higgins, Arlene Forastiere, Shanthi Marur
The New England Journal of Medicine|September 21, 2022
Trastuzumab Deruxtecan in HER2-Low Breast CancerHailey K Carroll, Michaela J Higgins, Seamus O'Reilly
Current Breast Cancer Reports|November 29, 2014
The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular CharacterizationSasmit Sarangi, Kailash Mosulpuria, Michaela J Higgins, et al.
Acta Oncologica (Stockholm, Sweden)|December 14, 2011
Denosumab and the current status of bone-modifying drugs in breast cancerBrittany L Lee, Michaela J Higgins, Paul E Goss
Breast Care (Basel, Switzerland)|August 9, 2017
Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast CancerDara B Bracken-Clarke, Mairi W Lucas, Michaela J Higgins
Critical Reviews in Oncology/Hematology|November 3, 2012
Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trialMichaela J Higgins, Pedro E R Liedke, Paul E Goss
Pageof 5